Literature DB >> 21240269

Crystal structure of autotaxin and insight into GPCR activation by lipid mediators.

Hiroshi Nishimasu1, Shinichi Okudaira, Kotaro Hama, Emiko Mihara, Naoshi Dohmae, Asuka Inoue, Ryuichiro Ishitani, Junichi Takagi, Junken Aoki, Osamu Nureki.   

Abstract

Autotaxin (ATX, also known as Enpp2) is a secreted lysophospholipase D that hydrolyzes lysophosphatidylcholine to generate lysophosphatidic acid (LPA), a lipid mediator that activates G protein-coupled receptors to evoke various cellular responses. Here, we report the crystal structures of mouse ATX alone and in complex with LPAs with different acyl-chain lengths and saturations. These structures reveal that the multidomain architecture helps to maintain the structural rigidity of the lipid-binding pocket, which accommodates the respective LPA molecules in distinct conformations. They indicate that a loop region in the catalytic domain is a major determinant for the substrate specificity of the Enpp family enzymes. Furthermore, along with biochemical and biological data, these structures suggest that the produced LPAs are delivered from the active site to cognate G protein-coupled receptors through a hydrophobic channel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21240269     DOI: 10.1038/nsmb.1998

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  46 in total

1.  Expression of autotaxin mRNA in human hepatocellular carcinoma.

Authors:  G Zhang; Z Zhao; S Xu; L Ni; X Wang
Journal:  Chin Med J (Engl)       Date:  1999-04       Impact factor: 2.628

2.  Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.

Authors:  Laurens A van Meeteren; Paula Ruurs; Evangelos Christodoulou; James W Goding; Hideo Takakusa; Kazuya Kikuchi; Anastassis Perrakis; Tetsuo Nagano; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2005-03-15       Impact factor: 5.157

3.  Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family.

Authors:  Hideki Sakagami; Junken Aoki; Yumiko Natori; Kiyotaka Nishikawa; Yoshiyuki Kakehi; Yasuhiro Natori; Hiroyuki Arai
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

4.  An essential oligomannosidic glycan chain in the catalytic domain of autotaxin, a secreted lysophospholipase-D.

Authors:  Silvia Jansen; Nico Callewaert; Isabelle Dewerte; Maria Andries; Hugo Ceulemans; Mathieu Bollen
Journal:  J Biol Chem       Date:  2007-02-16       Impact factor: 5.157

5.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.

Authors:  J J Contos; N Fukushima; J A Weiner; D Kaushal; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

6.  Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D.

Authors:  Silvia Jansen; Cristiana Stefan; John W M Creemers; Etienne Waelkens; Aleyde Van Eynde; Willy Stalmans; Mathieu Bollen
Journal:  J Cell Sci       Date:  2005-06-28       Impact factor: 5.285

7.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

8.  Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.

Authors:  Kotaro Hama; Junken Aoki; Masahiro Fukaya; Yasuhiro Kishi; Teruyuki Sakai; Rika Suzuki; Hideo Ohta; Takao Yamori; Masahiko Watanabe; Jerold Chun; Hiroyuki Arai
Journal:  J Biol Chem       Date:  2004-01-26       Impact factor: 5.157

9.  Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma.

Authors:  Akiko Masuda; Kazuhiro Nakamura; Koji Izutsu; Koji Igarashi; Ryunosuke Ohkawa; Masahiro Jona; Katsumi Higashi; Hiromitsu Yokota; Shinichi Okudaira; Tatsuya Kishimoto; Takuro Watanabe; Yukako Koike; Hitoshi Ikeda; Yasushi Kozai; Mineo Kurokawa; Junken Aoki; Yutaka Yatomi
Journal:  Br J Haematol       Date:  2008-08-15       Impact factor: 6.998

10.  Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization.

Authors:  M J Stassar; G Devitt; M Brosius; L Rinnab; J Prang; T Schradin; J Simon; S Petersen; A Kopp-Schneider; M Zöller
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

View more
  96 in total

1.  Target highlights in CASP9: Experimental target structures for the critical assessment of techniques for protein structure prediction.

Authors:  Andriy Kryshtafovych; John Moult; Sergio G Bartual; J Fernando Bazan; Helen Berman; Darren E Casteel; Evangelos Christodoulou; John K Everett; Jens Hausmann; Tatjana Heidebrecht; Tanya Hills; Raymond Hui; John F Hunt; Jayaraman Seetharaman; Andrzej Joachimiak; Michael A Kennedy; Choel Kim; Andreas Lingel; Karolina Michalska; Gaetano T Montelione; José M Otero; Anastassis Perrakis; Juan C Pizarro; Mark J van Raaij; Theresa A Ramelot; Francois Rousseau; Liang Tong; Amy K Wernimont; Jasmine Young; Torsten Schwede
Journal:  Proteins       Date:  2011-10-21

2.  Ligand-based autotaxin pharmacophore models reflect structure-based docking results.

Authors:  Catrina D Mize; Ashley M Abbott; Samantha B Gacasan; Abby L Parrill; Daniel L Baker
Journal:  J Mol Graph Model       Date:  2011-09-18       Impact factor: 2.518

Review 3.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

4.  Expression, purification, crystallization and preliminary X-ray crystallographic analysis of Enpp1.

Authors:  Kazuki Kato; Hiroshi Nishimasu; Emiko Mihara; Ryuichiro Ishitani; Junichi Takagi; Junken Aoki; Osamu Nureki
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-06-27

5.  Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells.

Authors:  Zachary Fulkerson; Tao Wu; Manjula Sunkara; Craig Vander Kooi; Andrew J Morris; Susan S Smyth
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

6.  ONO-8430506: A Novel Autotaxin Inhibitor That Enhances the Antitumor Effect of Paclitaxel in a Breast Cancer Model.

Authors:  Yuzo Iwaki; Akira Ohhata; Shingo Nakatani; Katsuya Hisaichi; Yasuyuki Okabe; Atsushi Hiramatsu; Toshihide Watanabe; Shingo Yamamoto; Taihei Nishiyama; Juta Kobayashi; Yasuo Hirooka; Hideki Moriguchi; Tatsuo Maeda; Makoto Katoh; Yuka Komichi; Hiroto Ota; Naoya Matsumura; Masahiro Okada; Tetsuya Sugiyama; Hiroshi Saga; Akira Imagawa
Journal:  ACS Med Chem Lett       Date:  2020-05-14       Impact factor: 4.345

7.  Location, location, location: a crystal-clear view of autotaxin saturating LPA receptors.

Authors:  Adel Tabchy; Gabor Tigyi; Gordon B Mills
Journal:  Nat Struct Mol Biol       Date:  2011-02       Impact factor: 15.369

8.  Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.

Authors:  Jerold Chun; Yasuyuki Kihara; Deepa Jonnalagadda; Victoria A Blaho
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

Review 9.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

10.  Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design.

Authors:  Spencer B Jones; Lance A Pfeifer; Thomas J Bleisch; Thomas J Beauchamp; Jim D Durbin; V Joseph Klimkowski; Norman E Hughes; Christopher J Rito; Yen Dao; Joseph M Gruber; Hai Bui; Mark G Chambers; Srinivasan Chandrasekhar; Chaohua Lin; Denis J McCann; Daniel R Mudra; Jennifer L Oskins; Craig A Swearingen; Kannan Thirunavukkarasu; Bryan H Norman
Journal:  ACS Med Chem Lett       Date:  2016-08-02       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.